Page last updated: 2024-10-29

ifosfamide and Carcinoma, Ductal, Breast

ifosfamide has been researched along with Carcinoma, Ductal, Breast in 3 studies

Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"We report three cases of women with breast cancer who developed renal impairment following treatment with high-dose ifosfamide."7.70Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients. ( Hill, PA; Power, DA; Prince, HM, 2000)
"We report three cases of women with breast cancer who developed renal impairment following treatment with high-dose ifosfamide."3.70Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients. ( Hill, PA; Power, DA; Prince, HM, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mollenkopf, A1
du Bois, A1
Meerpohl, HG1
Hill, PA1
Prince, HM1
Power, DA1
Johnstone, EC1
Lind, MJ1
Griffin, MJ1
Boddy, AV1

Other Studies

3 other studies available for ifosfamide and Carcinoma, Ductal, Breast

ArticleYear
[Sequential course and prospective management of ifosfamide-induced multi-organ toxicity].
    Geburtshilfe und Frauenheilkunde, 1996, Volume: 56, Issue:10

    Topics: Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modal

1996
Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients.
    Pathology, 2000, Volume: 32, Issue:3

    Topics: Adult; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Ductal, Breast; Contraindicat

2000
Ifosfamide metabolism and DNA damage in tumour and peripheral blood lymphocytes of breast cancer patients.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:6

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma,

2000